Achieving FDA and EMA Compliance in Temperature Monitoring

Freezer for temperature monitoring.
Document
Achieving FDA and EMA Compliance in Temperature Monitoring

Pharmaceuticals and biologics often require strict temperature control to stay safe and effective. Deviation from these conditions can cause degradation. Regulatory bodies like the FDA and EMA enforce strict guidelines to ensure product quality during manufacturing, storage, and transport.

Many pharmaceuticals and biological products require specific temperature conditions during manufacturing, storage, and transport to ensure their quality and safety. Failure to maintain these conditions can lead to product degradation, making them less effective or even dangerous.
Key Considerations for Life Science Companies

To protect public health, regulatory authorities like the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) have established strict guidelines to manage these products. To comply with these regulations, life science companies must adopt advanced temperature monitoring systems that can track and record conditions continuously and reliably.

This whitepaper explains the main requirements from both the FDA and EMA, the role of technology in maintaining compliance, and the best practices for setting up effective temperature monitoring systems.

You may also be interested in

The EcoVadis Silver 2023 Sustainability Rating medal next to hands holding planet Earth, symbolizing TSS's achievement.

TSS Achieves EcoVadis Silver Medal for Advanced Sustainability Performance

TSS, a leading Swedish Software-as-a-Service (SaaS) company specializing in automated temperature monitoring solutions, is thrilled to announce that it has been awarded the prestigious EcoVadis Silver Medal for its advanced sustainability performance. With an overall score of 65, TSS has secured its position among the top 13% of sustainable world-leading companies, firmly establishing itself as a trailblazer in the industry.
Read moreDownload Whitepaper
A warehouse interior, illustrating the pharmaceutical supply chain.

End-to-end visibility is the key to creating more efficient, cost-effective, and sustainable pharmaceutical supply chains

Pharmaceutical supply chains are often defined by a lack of connectivity between tiers, stakeholders and operational islands. It doesn’t have to be that way.
Read moreDownload Whitepaper
A person wearing blue gloves and a lab coat is handling a large metal plate, partially immersing it into an industrial liquid tank in a laboratory.

TSS Named a Di Gasell 2025

We’re proud to share that TSS has been recognized as a Di Gasell 2025, an award from the national financial newspaper Dagens industri celebrating Sweden’s fastest-growing and most successful companies.
Read moreDownload Whitepaper

You may also be interested in

How To Minimise the Environmental Impact of Cloud Operations

When people think about sustainability transitions in pharmaceutical supply chains, they often focus on reducing product waste, or optimising transportation. These are both important initiatives, but there's another part of the equation that often goes unnoticed: the digital infrastructure powering modern supply chains.
Read more
A map of Europe with flags marking the different countries, representing the international audience of LogiPharma Europe 2025.

Join Us at LogiPharma Europe 2026

From Temperature Data to Release Decisions—Rethinking Supply Chain Control
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.